ARCH Venture Fund XIII reports acquisition of $25 million in Lyell Immunopharma common shares
LYEL•ARCH Venture Fund XIII purchased 2,321,262 Lyell Immunopharma shares at $10.77 each, increasing its holdings to 3,747,790 shares.
1. Share purchase
ARCH Venture Fund XIII purchased 2,321,262 shares of Lyell Immunopharma common stock at $10.77 per share. The purchase increased the fund’s holdings to 3,747,790 shares.
